首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

多體學市場規模、佔有率和成長分析（按產品/服務、類型、平台、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1913241

多體學市場規模、佔有率和成長分析（按產品/服務、類型、平台、應用、最終用戶和地區分類）—2026-2033年產業預測

Multiomics Market Size, Share, and Growth Analysis, By Products and Services (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月02日 | 出版商:

SkyQuest | 英文 176 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球多體學市場規模將達到 36.1 億美元，到 2025 年將達到 42 億美元，到 2033 年將達到 141.5 億美元，在預測期（2026-2033 年）內，複合年成長率為 16.4%。

全球多體學領域正經歷顯著成長，這主要得益於人們對個人化醫療日益成長的興趣、基因組學和蛋白質組學領域的大量投資，以及多組體學在藥物研發和臨床診斷中應用範圍的不斷擴大。定序技術和數據分析的進步推動了這一成長，而醫療保健格局在製藥和研究領域也在不斷演變。慢性病發病率的上升以及生物醫學研究領域大量的公共和私人資金投入，都推動了對多體學的需求。製藥公司正擴大採用多體學技術來簡化藥物研發流程並識別新的治療標靶。然而，高昂的研發成本、熟練專家的短缺、數據整合問題以及標準化程度有限等挑戰，可能會阻礙其未來的市場滲透。

全球多體學市場促進因素

全球多體學市場受到個人化醫療需求日益成長的顯著影響，而基因組學、蛋白質組學和代謝體學等技術的應用正是推動個人化治療方法發展的關鍵因素。這些先進工具使醫療專業人員能夠根據個人獨特的基因和生物學特徵制定個人化治療方案。因此，醫院、製藥公司和研究機構正擴大採用多體學方法來增強藥物標靶化和提高診斷準確性。社會對更有效、更快速的治療方法的需求不斷成長，進一步強化了對個人化、數據驅動型醫療解決方案的關注。因此，多組體學正逐漸成為現代醫療實踐的重要組成部分。

限制全球多組體學市場的因素

全球多體學市場面臨許多限制因素，主要源自於建立和維護多組體學實驗室的高昂成本。必要的配套基礎設施，包括先進設備、專用軟體和充足的數據存儲，價格可能極其昂貴，尤其是在發展中地區，這些工具難以取得。此外，儘管市場對能夠有效管理和解讀多體學研究產生的複雜數據的專業人員需求旺盛，但合格的專業人員卻嚴重短缺。這些經濟負擔，加上人員短缺的挑戰，阻礙了多組體學在資源匱乏地區的發展和擴張。

全球多體學市場趨勢

將多體學技術整合到臨床應用和精準醫療中，是全球多組體學市場的一大顯著趨勢。該領域的企業正優先開發針對癌症、心血管疾病和神經系統疾病的專用診斷工具，以促進早期發現並加強治療監測。隨著對個人化醫療解決方案的需求日益成長，多組體學在臨床實踐中的應用正為患者管理的創新方法鋪平道路。這項發展不僅使市場參與者在競爭格局中脫穎而出，也為精準醫療的成長和進步創造了廣闊的機遇，最終將改善患者預後並提高醫療效率。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（United States）
Illumina, Inc.（United States）
Danaher Corporation（United States）
QIAGEN NV（Germany）
Agilent Technologies, Inc.（United States）
PerkinElmer, Inc.（United States）
Bruker Corporation（United States）
Becton, Dickinson and Company（BD）（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
10x Genomics, Inc.（United States）
Shimadzu Corporation（Japan）
BGI Genomics（China）
Bio-Rad Laboratories, Inc.（United States）
Mission Bio, Inc.（United States）
Standard BioTools（United States）
NanoString Technologies（United States）
CYTENA GmbH（Germany）
Tempus Labs, Inc.（United States）
DNAnexus, Inc.（United States）
Eurofins Scientific SE（Luxembourg）

結論與建議

簡介目錄

Product Code: SQMIG35G2367

Global Multiomics Market size was valued at USD 3.61 Billion in 2024 and is poised to grow from USD 4.2 Billion in 2025 to USD 14.15 Billion by 2033, growing at a CAGR of 16.4% during the forecast period (2026-2033).

The global multiomics sector is experiencing significant growth driven by heightened interest in personalized medicine, robust investments in genomics and proteomics, and an increasing application of multiomics for drug discovery and clinical diagnostics. Technological advancements in sequencing and data analysis are facilitating this expansion, while the healthcare landscape continues to evolve within pharmaceutical and research domains. The demand for multiomics is being propelled by the rising prevalence of chronic diseases and substantial public and private funding in biomedical research. Pharmaceutical firms are adopting multiomics technologies to streamline drug discovery and identify new therapeutic targets. Nonetheless, challenges such as high research costs, a shortage of skilled professionals, data integration issues, and limited standardization may impede further market penetration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multiomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multiomics Market Segments Analysis

Global Multiomics Market is segmented by Products and Services, Type, Platform, Application, End User and region. Based on Products and Services, the market is segmented into Products and Services. Based on Type, the market is segmented into Single-cell Multiomics and Bulk Multiomics. Based on Platform, the market is segmented into Genomics, Transcriptomics, Proteomics, Metabolomics and Integrated Omics Platforms. Based on Application, the market is segmented into Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics and Others. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Multiomics Market

The global multiomics market is significantly influenced by the rising demand for personalized medicine, which leverages technologies like genomics, proteomics, and metabolomics. These advanced tools empower healthcare professionals to develop tailored treatments that cater to individuals' unique genetic and biological profiles. As a result, hospitals, pharmaceutical companies, and research laboratories are increasingly adopting multiomics approaches to enhance drug targeting and improve diagnostic accuracy. With a growing public desire for more effective and expedited treatment options, the focus on personalized, data-driven healthcare solutions intensifies. Consequently, multiomics is emerging as an essential component in modern healthcare practices.

Restraints in the Global Multiomics Market

The Global Multiomics market faces significant constraints primarily due to the high costs associated with setting up and maintaining multiomics laboratories. The necessary infrastructure, including advanced instruments, specialized software, and ample data storage, can be prohibitively expensive, especially in developing regions where facilities often struggle to acquire these tools. Additionally, there is a considerable demand for skilled personnel who can effectively manage and interpret the intricate data generated by multiomics studies, yet there is a notable shortage of such qualified professionals. This combination of financial burdens and staffing challenges hinders the growth and expansion of multiomics in resource-constrained environments.

Market Trends of the Global Multiomics Market

The Global Multiomics market is witnessing a significant trend towards the integration of multiomics technologies in clinical applications and precision medicine. Companies in this sector are prioritizing the development of diagnostic tools tailored to oncology, cardiovascular, and neurological disorders, which facilitate early detection and enhance treatment monitoring. As the demand for personalized healthcare solutions grows, the translation of multiomics into clinical practice paves the way for innovative approaches to patient management. This evolution not only distinguishes market players in a competitive landscape but also opens up expansive opportunities for growth and advancement in precision medicine, ultimately improving patient outcomes and healthcare efficiency.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Multiomics Market Size by Products and Services & CAGR (2026-2033)

Market Overview
Products
- Instruments
- Consumables
- Software
Services

Global Multiomics Market Size by Type & CAGR (2026-2033)

Market Overview
Single-cell Multiomics
Bulk Multiomics

Global Multiomics Market Size by Platform & CAGR (2026-2033)

Market Overview
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms

Global Multiomics Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostics
Drug Discovery and Development
Personalized Medicine
AgriGenomics
Others

Global Multiomics Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Research Organizations (CROs)
Others

Global Multiomics Market Size & CAGR (2026-2033)

North America (Products and Services, Type, Platform, Application, End User)
- US
- Canada
Europe (Products and Services, Type, Platform, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Products and Services, Type, Platform, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Products and Services, Type, Platform, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Products and Services, Type, Platform, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mission Bio, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CYTENA GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tempus Labs, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNAnexus, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific S.E. (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments